Search for Abstracts Find by Title, Author or Description Year Abstracts - 2022 - 2021 - 2020 - 2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 Tags AB Applied Basic Science Basic Science BT Clinical Clinical-Chemotherapy-SSA-Biologics Clinical-PRRT-Nuclear Clinical-Surgical-Applied_Pathology OT Other P Population Science Poster T Trials In Progress Search Reset Order by Title Alphabetical Title Reverse Alphabetical Most Recent First Oldest First Most popular first Last modified first C01 – An Open-label, Phase II Study Evaluating the Safety and Efficacy of PTK787/ZK222584 in Patients with Metastatic Neuroendocrine Tumors that Have Evidence of Progressive Disease or an Increase in Disease Related Syndrome Symptoms Published in 2009 Listed under Clinical Download Lowell B. Anthony, Maria M. Chester, Bernard J. Brown, Stacy L. Michael, Jacky R. Seward, M. Sue O’Dorisio, Thomas M. O’Dorisio C01 – Assessing Treatment Benefit of Telotristat Etiprate in Patients with Carcinoid Syndrome: Patient Exit Interviews Published in 2015 Listed under Clinical Download Anthony; Hörsch; Ervin; Kulke; Pavel; Bergsland; Caplin; Oberg; Warner; Kunz; Metz; Pasieka; Pavlakis; DiBenedetti; Haydysch; Yang; Jackson; Arnold; Law; Lapuerta C01 – Czech Registery of Neuroendocrine Neoplasms (NEN) Published in 2013 Listed under Clinical Download Barkmanova C01 – Incidence, Prevalence and Survival of Patients with Small Bowel Neuroendocrine Tumors (MGC) Excluding Appendiceal Tumors: A Northern Ireland (NI) Study Over 25 years Published in 2014 Listed under Clinical Download Ardill C01 – Laboratory Diagnosis of Gastrinoma Remains Difficult Published in 2012 Listed under Clinical, Poster Download Joy Ardill; Lee Armstrong; Brian Johnston; David McCance pdf Download Poster (81 KB) C01 – Preliminary Safety and Efficacy of Rovalpituzumab Tesirine in Patients with Delta-Like Protein 3-Expressing Advanced Solid Tumors Published in 2017 Listed under Clinical, Poster Download Aggarwal Abstract ID: 229 pdf Download Poster (795 KB) C01 – Presence of Extra-Hepatic Disease Should Not Preclude Transarterial Chemoembolization for Metastatic Carcinoid Published in 2010 Listed under Clinical, Poster Download Arrese David, Feria-Arias Enrique, Hatzaras Ioannis, Guy Gregory, Khabiri Hooman, Schmidt Carl, Shah Manisha, Bloomston Mark pdf Download Poster (3.54 MB) C01 – Simulated-Use Study of a Single-Use Delivery Device for Lanreotide Depot in Untrained Health Care Professionals Published in 2016 Listed under Clinical, Poster Download Adelman pdf Download Poster (5.41 MB) C01 – Evaluation of the Efficacy and Safety of Lanreotide on Tumor Growth Stabilization in Patients with Progressive NETs Who Are Not Eligible for Treatment with Surgery or Chemotherapy Published in 2011 Listed under Clinical, Poster Download Vicente Alonso, Maribel Marmol, Daniel Castellano, Emilio Fonseca, Amalia Velasco, José Luis García López, Eva Pineda, Pascal Maisonobe, Bertomeu Massutí, Marta Martín-Richard, on behalf of the TTD Study Group pdf Download Poster (213 KB) C02 – A Systematic Literature Review on the Efficacy and Safety of Octreotide Long-Acting Repeatable Used at Higher than FDA-Approved Doses and/or Frequencies for Treatment of Neuroendocrine Tumors Published in 2013 Listed under Clinical Download Broder C02 – Biomarkers in Late Stage Neuroendocrine Tumors of the Small Bowel Published in 2015 Listed under Clinical Download Ardill; Stronge; McDance; Johnston C02 – Health-related Quality of Life of Patients with Neuroendocrine Tumor Compared to the United States General Population Published in 2009 Listed under Clinical, Poster Download Jennifer L. Beaumont, Zhimei Liu, Seung Choi, James C. Yao, David Cella pdf Download Poster (194 KB) C02 – Impact of Prior Somatostatin Analogue (SSA) Use on Progression-free Survival (PFS) in Patients with Advanced Nonfunctional Neuroendocrine Tumors (NET) of Lung or Gastrointestinal (GI) Origin: A Secondary Analysis from the RADIANT-4 Study Published in 2016 Listed under Clinical Download Buzzoni C02 – Neurokinin A is a Sensitive Circulating Biomarker for Neuroendocrine Tumours of the Midgut. Audit of 1000 Consecutive Raised NKA Results in a Routine Regulatory Peptide Laboratory Published in 2012 Listed under Clinical, Poster Download Joy Ardill; Lee Armstrong; David McCance; Brian Johnston pdf Download Poster (112 KB) C02 – Outcomes of Locoregional Treatment for Unifocal Progression in Widespread Metastatic Gastroenteropancreatic Neuroendocrine Tumors Published in 2017 Listed under Clinical, Poster Download Al-Toubah Abstract ID: 241 pdf Download Poster (450 KB) C02 – Poor Prognosis in Spontaneous Gastrinoma When Additional Hormones and Peptides are Secreted Published in 2014 Listed under Clinical Download Ardill C02 – Short Term Response to Systemic I-131 MIBG Therapy in Metastatic Carcinoid Tumors. Published in 2010 Listed under Clinical Download Richard J Campeau MD, Lowell B Anthony MD, Eugene A Woltering MD, Yi-Zarn Wang MD, and J Phillip Boudreaux MD C02 – Impact of Prior Somatostatin Analog Use on PFS in the Phase III RADIANT-2 Trial of Everolimus + Octreotide LAR vs Placebo + Octreotide LAR in Patients with Advanced Neuroendocrine Tumors Published in 2011 Listed under Clinical, Poster Download Lowell Anthony, Neha Singh, Vanessa Q. Passos, Marianne Pavel, Kjell Oberg, James C. Yao pdf Download Poster (232 KB) C03 – Neurokinin A is a Sensitive Prognostic Indicator for Neuroendocrine Tumours of the Midgut and is Useful to the Clinician When Considering Treatment Options Published in 2012 Listed under Clinical, Poster Download Joy Ardill; Lee Armstrong; David McCance; Brian Johnston pdf Download Poster (150 KB) C03 – Escalated Dose Somatostatin Analogues (SSA) in Management of NETs: A Systematic Review Published in 2016 Listed under Clinical Download Chan C03 – Gluteal Intramuscular Injections: Techniques Associated with Successful Octreotide LAR Injection Published in 2009 Listed under Clinical, Poster Download April E. Boyd, Colleen C. Leary, James P. Brook, Valentine G. Boving, Cecile G. Dagohoy, Linda L. DeFord, Jeana L. Garris, Jeannette E. Mares, Alexandria T. Phan, James C. Yao pdf Download Poster (122 KB) C03 – Health-Related Quality of Life (HRQL) in Patients With Uncontrolled Neuroendocrine Tumor (NET) Symptoms Published in 2014 Listed under Clinical Download Beaumont C03 – Octreotide LAR in Patients with Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH): A Case Series Published in 2013 Listed under Clinical Download Byron C03 – Prognostic Criteria Development for Metastatic Well- or moderately-differentiated Neuroendocrine Tumors Published in 2010 Listed under Clinical, Poster Download Lisa M. Caronia, David Arrese, Lai Wei, Carl R. Schmidt, Daria Arbogast, Mark P. Bloomston, Manisha H. Shah pdf Download Poster (366 KB) C03 – Response to Interferon Alpha (IFA) in Patients with Small Bowel Neuroendocrine Tumors (SB-NETs) Published in 2015 Listed under Clinical Download Ardill; Johnston; McCance C03 – Systematic Literature Review of Octreotide's Antitumor Effects in Neuroendocrine Tumors Published in 2017 Listed under Clinical, Poster Download Barrows Abstract ID: 221 pdf Download Poster (233 KB) C03 – A Phase II Study to Evaluate the Safety and Efficacy of RAD001 plus Erlotinib in Patients with Well-Differentiated Neuroendocrine Tumors (NET) Published in 2011 Listed under Clinical Download Emily Bergsland, Lindsey Watt, Andrew Ko, Margaret Tempero, W. Michael Korn, Robin K. Kelley, Tom Weber, Iche Siah, Jimmy Hwang, Eric Nakakura, Alan Venook C04 – Complete Response to Combination Therapy with 177- Lutetium PRRT and Capecitabine in the Treatment of Thymic Squamous Cell Carcinoma Published in 2015 Listed under Clinical Download Armaghany; Vahdati; Broline; Hamiditabar; Goshen; Rogosnitzky; Giannikopoulos; Caulin; Polkinghorn; Delpassand C04 – Efficacy and Safety of Everolimus in Advanced, Progressive ,Nonfunctional Neuroendocrine Tumors (NET) of the Lung: A Subgroup Analysis of the Phase 3 RADIANT-4 Study Published in 2016 Listed under Clinical, Poster Download Fazio pdf Download Poster (485 KB) C04 – Lanreotide Autogel Significantly Improves Tumor Progression-Free Survival in Patients with Non-Functioning Gastroenteropancreatic Neuroendocrine Tumors: Results of the CLARINET Study Published in 2013 Listed under Clinical Download Caplin C04 – Long Term Effects of Surgical Resection of Pheochromocytoma or Paraganglioma on Body Weights: A Retrospective Cohort Study Published in 2014 Listed under Clinical Download Bennett C04 – LX1032: A Novel Agent to Reduce Serotonin In Carcinoid Syndrome Published in 2009 Listed under Clinical, Poster Download Philip Brown, Kenny Frazier, Shanna Jackson, Anne Turnage, Qingyun Liu pdf Download Poster (730 KB) C04 – Phase I Study of Pasireotide (SOM230) in Combination with Everolimus (RAD001) in Patients with Advanced Neuroendocrine Tumors (NET) Published in 2010 Listed under Clinical, Poster Download Jennifer A. Chan, MD, MPH,; David P. Ryan, MD; Charles S. Fuchs, MD, MPH,; Andrew X. Zhu, MD, PhD; Thomas A. Abrams, MD, Brian M. Wolpin, MD, MPH,; Carolyn Casey, BS; Eileen Regan, RN, BSN, OCN; Kristen Cavanaugh, RN; Matthew H. Kulke, MD, MMSc pdf Download Poster (112 KB) C04 – Phase II Trial of Cabozantinib in Patients with Carcinoid and Pancreatic Neuroendocrine Tumors Published in 2017 Listed under Clinical Download Chan Abstract ID: 290 C04 – Sustained Response to Alpha Interferon in a Patient with an Advanced Metastatic Serotonin Secreting Endocrine Tumour - Case Report Published in 2012 Listed under Clinical, Poster Download Joy Ardill; Lee Armstrong; Brian Johnston; David McCance pdf Download Poster (79 KB) C04 – The CLARINET Study -- Assessing the Effect of Lanreotide Autogel on Tumor Progression-Free Survival in Patients with Non-Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Published in 2011 Listed under Clinical Download Blumberg Joelle, Liyanage Nilani, Caplin Martyn, on behalf of UK & Ireland Neuroendocrine Tumour Society/European Neuroendocrine Tumor Society C05 – An Expert Panel Consensus on Medical Treatement of Non-Midgut Unresectable Neuroendocrine Tumors Published in 2012 Listed under Clinical, Poster Download Al B. Benson; Jonathan R. Strosberg; George A. Fisher; Jennifer L. Malin; Lowell B. Anthony; Bulent Arslan; John F. Gibbs; Edward Greeno; Renuka V. Iyer; Michelle K. Kim; William J. Maples ; Philip. A. Philip; Edward M. Wolin; Dasha Cherepanov; Michael S. Broder pdf Download Poster (291 KB) C05 – Efficacy of Lanreotide Depot/Autogel for Symptomatic Control of Carcinoid Syndrome (CS) in Neuroendocrine Tumor Patients: Follow-up Analysis of the ELECT Prospective, Randomized, Doubleblind and Open-label Phases Published in 2016 Listed under Clinical, Poster Download Fisher, Jr pdf Download Poster (927 KB) C05 – Phase I Study of Sorafenib in Combination with Everolimus (RAD001) in Patients with Advanced Neuroendocrine Tumors (NET) Published in 2010 Listed under Clinical, Poster Download Jennifer A. Chan, MD, MPH,; Robert J. Mayer, MD,; Nadine Jackson, MD, MPH,; Paige Malinowski, BA; Eileen Regan, RN, BSN, OCN; Matthew H. Kulke, MD, MMSc pdf Download Poster (105 KB) C05 – Succinate Dehydrogenase Subunit B (SDHB) Immunohistochemistry Should Not Replace Clinical Genetic Testing for SDHx Mutations in Patients with Pheochromocytoma and Paraganglioma Published in 2013 Listed under Clinical Download Fishbein C05 – Surgical Management of Neuroendocrine Tumors Metastatic to the Liver Published in 2009 Listed under Clinical Download Scott Celinski MD, Jennifer Steel PhD, Kevin Tri Nguyen MD PhD, J. Wallis Marsh MD, David A. Geller MD, Richard Raizman MD, Allan Tsung MD, T. Clark Gamblin MD, MS C05 – Theranostics with I-131/I-123 Meta-Iodobenzylguanidine (MIBG) in Stage IV Advanced Malignant Neuroendocrine Tumors Published in 2014 Listed under Clinical Download Campeau C05 – Time to Sustained Improvement in Bowel Movement Frequency With Telotristat Ethyl: Analysis of the Phase 3 TELESTAR Study Published in 2017 Listed under Clinical, Poster Download Dillon Abstract ID: 255 pdf Download Poster (728 KB) C05 – Treatment of High Grade Metastatic Neuroendocrine Tumor (mNET) with Peptide Receptor Radionuclide Therapy (PRRT) Retrospective Analysis in a Single Referral Center Published in 2015 Listed under Clinical Download Armaghany; Vahdati; Amerinia; Hamiditabar; Tamaski; Delpassand C05 – Improved Tumor Dosimetry by Combining 131I-MIBG and 90Y-DOTATOC in Patients with Carcinoid Tumors Published in 2011 Listed under Clinical, Poster Download David Bushnell, Mark Madsen, Tom O'Dorisio, Yusuf Menda, Beth Schmitt, Thorvardur Halfdanarson, Sue O'Dorisio pdf Download Poster (417 KB) C06 – An Exploratory Patient Centric Analysis of the ELECT Trial: A Phase 3 Study of Efficacy and Safety of Lanreotide Autogel/Depot (LAN) Treatment for Patients (pts) with Carcinoid Syndrome (CS) Published in 2017 Listed under Clinical Download Duchateau Abstract ID: 222 C06 – Antitumor Effects with Lanreotide Autogel/Depot (LAN) in Patients with Metastatic Enteropancreatic (EP) Neuroendocrine Tumors (NETs): Interim Results of the CLARINET Extension Study Published in 2014 Listed under Clinical Download Caplin C06 – Cumulative Safety Experience of Telotristat Etiprate in Clinical Trials Supports Advancement to Phase 3 Published in 2013 Listed under Clinical Download Fleming C06 – Description of Initial Treatment for Newly Diagnosed Metastatic Carcinoid (cNET) and Pancreatic Neuroendocrine (pNET) Patients Published in 2012 Listed under Clinical, Poster Download Sarah Bobiack, PhD; Michael A. Choti, MD; Al B. Benson, III MD; Jonathan R. Strosberg, MD; P. Mark Bloomston, MD; Emily K. Bergsland, MD; Carrie C. Zornosa, MSPH; Matthew H. Kulke, MD; Eric K. Nakakura, MD; Manisha H. Shah, MD; James C. Yao, MD pdf Download Poster (862 KB) C06 – Economic Evaluation of Octreotide LAR Versus Lenreotide Depot in the Treatment of Metastatic Gastrointestinal Neuroendocrine Tumors Published in 2015 Listed under Clinical Download Ayyagari; Neary; Li; Zhao; Higuchi; Xie; Benson C06 – Incidental Diagnosis of Pancreatic Neuroendocrine tumors Published in 2010 Listed under Clinical, Poster Download Asima Cheema MD, Jill Weber MPH, Larry Kvols MD, Jonathan Strosberg, MD pdf Download Poster (60 KB) C06 – One year Follow-up for the Phase I MTD study of Ultratrace Iobenguane I 131 in Patients with Malignant Pheochromocytoma/Paraganglioma (Pheo) Published in 2009 Listed under Clinical, Poster Download R. Edward Coleman, Stanley J. Goldsmith, Richard B. Noto, Kimberly R. Pearson, Katherine A. Kacena, John A. Barrett, Norman D. LaFrance, John W. Babich Corresponding author pdf Download Poster (739 KB) C06 – Pharmacokinetic (PK) Differences Between Subcutaneous and Intramuscular Administration of Lanreotide: Results from a Phase I Study Published in 2016 Listed under Clinical, Poster Download Manon pdf Download Poster (2.26 MB) C06 – Impact of Progression on Resource Utilization in the Treatment of Advanced Neuroendocrine Tumor Published in 2011 Listed under Clinical, Poster Download R. Casciano, X. Wang, Z. Liu, R. Parikh, J. Strosberg, R. Riechelmann pdf Download Poster (324 KB) C07 – 5-Hydroxyindoleacetic Acid (5-HIAA) and Chromogranin A (CgA) as Biomarkers Secreted by Neuroendocrine Tumors (NETs): a Pooled Analysis of the ELECT and CLARINET Studies Published in 2017 Listed under Clinical Download Fisher, Jr Abstract ID: 232 C07 – A Study of BP Variability Utilizing 24 hour Ambulatory BP Monitoring in Patients with Catecholamine Secreting Neuroendocrine Tumors Before and After Tumor Resection Published in 2015 Listed under Clinical Download Bennett; Ganguli; Cohen; Townsend C07 – Capecitabine and Temozolomide (C/T) Combination Therapy in Patients (pts) with Advanced Neuroendocrine Neoplasms (aNEN) and the Role of O6-methylguanine-methyltransferase (MGMT) as a Potential Biomarker for Response Published in 2016 Listed under Clinical, Poster Download Owen pdf Download Poster (519 KB) C07 – Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) and the Role of Somatostatin Analogs Published in 2014 Listed under Clinical Download Chauhan C07 – Ki-67 Proliferative Index and the Tumor Grade Predict Progression Free Survival in Ileal Carcinoids Published in 2010 Listed under Clinical, Poster Download Deepti Dhall ,Rugvedita Parakh, Richard Mertens, Girish Dhall, Catherine Bresee, Delma Ines, Fai Chung, Marissa Li, Steven D Colquhoun, Nicholas N Nissen, Run Yu, HanlinWang and Edward Wolin pdf Download Poster (6.97 MB) C07 – Resection of Liver Metastasis in Midgut Neuroendocrine Tumors Affects 10-Year Survival Published in 2012 Listed under Clinical, Poster Download J. Philip Boudreaux MD; Anne E. Diebold BS; Yi-Zarn Wang MD; Eugene A. Woltering MD pdf Download Poster (211 KB) C07 – Transarterial Chemoembolization in Patients with Metastatic Carcinoid Amenable to Cytoreductive Hepatectomy Results in Improved Survival but Similar Regional Disease Control Compared to Those Deemed Inoperable Published in 2009 Listed under Clinical, Poster Download Feria-Arias, Enrique; Arrese, David; Hatzaras, Ioannis; Schmidt, Carl; Shah, Manisha; Bloomston, Mark pdf Download Poster (133 KB) C07 – Unusual Case of a Hormone-Secreting SDHC Head and Neck Paraganglioma Published in 2013 Listed under Clinical Download Ghayee C07 – Updated Results of a Phase I Study of Pasireotide (SOM230) in Combination with Everolimus in Patients (pts) with Advanced Neuroendocrine Tumors (NET) Published in 2011 Listed under Clinical, Poster Download Jennifer A. Chan, MD, MPH; David P. Ryan, MD; Charles S. Fuchs, MD, MPH; Andrew X. Zhu, MD, PhD; Thomas A. Abrams, MD, Brian M. Wolpin, MD, MPH; Paige Malinowski, BA; Eileen Regan, RN, BSN, OCN; Matthew H. Kulke, MD, MMSc pdf Download Poster (145 KB) C08 – Chemotherapy for Locally Advanced and Metastatic Pulmonary Carcinoid Tumors Published in 2014 Listed under Clinical Download Chong C08 – Efficacy and Safety Results of Telotristat Ethyl in Patients with Carcinoid Syndrome During the Double-blind Treatment Period of the TELECAST Phase 3 Clinical Trial Published in 2016 Listed under Clinical Download Pavel C08 – Evaluation of progression-free survival by blinded independent central review in patients with progressive, well-differentiated pancreatic neuroendocrine tumors treated with sunitinib or placebo Published in 2010 Listed under Clinical, Poster Download Pascal Hammel, Daniel Castellano, Eric Van Cutsem, Patricia Niccoli, Sandrine Faivre, Shem Patyna, Deno Klademenos, Dongrui Ray Lu, Richard Chao, Eric Raymond pdf Download Poster (385 KB) C08 – Gender Related Issues in Gluteal Intramuscular Injections Published in 2009 Listed under Clinical, Poster Download Jeana L. Garris, Linda L. DeFord, Cecile G. Dagohoy, Colleen C. Leary, Valentine G. Boving, James P. Brook, Jeannette E. Mares, April E. Boyd, Alexandria T. Phan, James C. Yao pdf Download Poster (428 KB) C08 – Lymph Node Positivity in Patients with Small T1 and T2 Midgut Neuroendocrine Tumors Published in 2012 Listed under Clinical, Poster Download J. Philip Boudreaux MD; Yi-Zarn Wang MD; Anne E. Diebold BS; Eugene A. Woltering MD pdf Download Poster (190 KB) C08 – Moving 68Ga-labeled DOTA PET Imaging Agents Towards Approval Published in 2013 Listed under Clinical Download Graham C08 – Nutritional Status and Nutritional Risk in Patients with Neuroendocrine Tumors Published in 2015 Listed under Clinical Download Borre; Knudsen; Dam; Gronbaek C08 – Phase I, Open-label, Dose-Escalation Study of SNX-5422 Plus Everolimus in Neuroendocrine Tumors (NETs) Published in 2017 Listed under Clinical, Poster Download Gutierrez Abstract ID: 249 pdf Download Poster (289 KB) C08 – The Use of Intraoperative Ultrasound Guided Radiofrequency Ablation for Cytoreductive Surgery of Liver Metastases from Pancreatic Neuroendocrine Tumors Published in 2011 Listed under Clinical, Poster Download Junsung Choi MD, Pamela J. Hodul MD, Larry K. Kvols MD, Jonathan Strosberg MD, Mokenge P. Malafa, MD pdf Download Poster (1.68 MB) C09 – A Phase I Study of Imatinib, Dacarbazine, and Capecitabine in Advanced Endocrine Cancers Published in 2013 Listed under Clinical Download Halperin C09 – A Phase II Study of Axitnib in Advanced Carcinoid Tumors Published in 2014 Listed under Clinical Download Cives C09 – Efficacy and Safety of Telotristat Ethyl in Patients With Carcinoid Syndrome Inadequately Controlled by Somatostatin Analogs: Analysis of the Completed TELESTAR Extension Period Published in 2017 Listed under Clinical, Poster Download Hörsch Abstract ID: 214 pdf Download Poster (724 KB) C09 – Impact of Prior Chemotherapy (Chemo) on Progression-free Survival (PFS) in Patients (Pts) with Advanced, Nonfunctional Lung or Gastrointestinal (GI) Neuroendocrine Tumors (NET): A Secondary Analysis from The Phase 3 RADIANT-4 Study Published in 2016 Listed under Clinical Download Pommier C09 – Phase I/II Study of Everolimus (RAD001) in Combination with Temozolomide (TMZ) in Patients with Advanced Pancreatic Neuroendocrine Tumors (NET) Published in 2010 Listed under Clinical, Poster Download Matthew H. Kulke, MD, MMSc,; Lawrence Blaszkowsky, MD; Andrew X. Zhu, MD, PhD; Sarah Florio, BS; Eileen Regan, RN, BSN, OCN; David P. Ryan, MD; Jennifer A. Chan, MD, MPH pdf Download Poster (110 KB) C09 – Preliminary Experience with Intra-arterial I-131 MIBG Hepatic Infusion for Progressive Metastatic Low Grade Neuroendocrine Tumors: An Ongoing Work-In-Progress Published in 2012 Listed under Clinical, Poster Download Richard J Campeau, MD, FACNM; Adam M Dowling, MD, FACR; Eugene A Woltering MD, FACS; J Philip Boudreaux, MD, FACS; Yi-Zarn Wang, MD, FACS; Maria M Chester, RN, BSN pdf Download Poster (414 KB) C09 – Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors (PNETs): A Single-Center Case Control Study Published in 2009 Listed under Clinical, Poster Download Thorvardur R. Halfdanarson, William R. Bamlet, Timothy J. Hobday, Robert R. McWilliams, Gloria M. Petersen. pdf Download Poster (39 KB) C09 – The Cost Impact of Non- Infectious Diarrhea in Patients with Carcinoid Syndrome Published in 2015 Listed under Clinical, Poster Download Broder; Chang; Cherepanov; Neary pdf Download Poster (249 KB) C09 – Comparison of Clinicopathologic Factors in 122 Patients with Resected Pancreatic and Ileal Neuroendocrine Tumors from a Single Institution Published in 2011 Listed under Clinical, Poster Download Fadi S. Dahdaleh, MD, Daniel Calva-Cerqueira, MD, Jennifer C. Carr, MD, Junlin Liao, PhD, James J. Mezhir, MD, Thomas M. O'Dorisio, MD, and James R. Howe, MD pdf Download Poster (1.08 MB) C1 - Long-Term Follow Up of Patients with Carcinoid Syndrome Diarrhea Treated with Telotristat Ethyl: A Pooled Analysis of Phase 2 and 3 Trials Published in 2018 Listed under Clinical, Poster Download Abstract ID: 37 Lowell Anthony, Matthew Kulke, Martyn Caplin, Emily Bergsland, Kjell Öberg, Marianne Pavel, Dieter Hörsch, Thomas O’Dorisio, Joseph Dillon, Pablo Lapuerta, Kenneth Kassler-Taub, Wenjun Jiang pdf Download Poster (1016 KB) C1 - The TELEPATH Phase 3 Study: An Analysis of Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms Published in 2019 Listed under Clinical Download Dieter Horsch; Lowell Anthony; David Gross; Juan Valle; Staffan Welin; Marta Benavent; Kenneth Kassler-Taub; Polina Binder; Phillip Banks; Pablo Lapuerta; Matthew Kulke Abstract ID: 33 C10 - CLARINET FORTE Baseline Characteristics: Lanreotide Autogel 120 Mg (LAN) Every 14 Days in Patients with Progressive Pancreatic or Midgut Neuroendocrine Tumors During a Standard First-Line LAN Regimen Published in 2019 Listed under Clinical Download Philippe Ruszniewski; Jarosław Ćwikła; Catherine Lombard-Bohas; Ivan Borbath; Tahir Shah; Ulrich-Frank Pape; Xuan-Mai Truong Thanh; Aude Houchard; Marianne Pavel Abstract ID: 121 C10 - Long-Acting Somatostatin Analogue Safety Monitoring Protocol for Outpatients with Neuroendocrine Tumors Published in 2018 Listed under Clinical, Poster Download Abstract ID: 20 Jordan Gabrielson, Gianna Girone, Bonita Bennett, Anna Jung pdf Download Poster (246 KB) C10 – Clinical Presentation and Management of Patients with Bone Metastases (BMet) from Neuroendocrine Tumors (NETs): Pooled Results from Two Institutional Databases Published in 2013 Listed under Clinical Download Keiser C10 – Early CgA Response as Predictor of Outcome Following Everolimus Therapy Among Patients with Low- to Intermediate- Grade Neuroendocrine Carcinoma: Published in 2009 Listed under Clinical, Poster Download Carmen B. Jacobs, Alexandria T. Phan, Robert A. Wolff, Funda Meric-Bernstam, James C. Yao pdf Download Poster (94 KB) C10 – Predictors of Somatostatin Analogs (SSA) Dose Escalations (DEs) Above Recommended Dosing Among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Treated at a Tertiary Referral Center Published in 2017 Listed under Clinical, Poster Download Jalbert Abstract ID: 277 pdf Download Poster (655 KB) C10 – Prevalence of Functional Tumors in Neuroendocrine Carcinoma: An Analysis from the NCCN NET Database. Published in 2012 Listed under Clinical, Poster Download Michael A. Choti, MD; Sarah Bobiak, PhD; Jonathan R. Strosberg, MD; Al B. Benson, III, MD; P. Mark Bloomston, MD; James C. Yao, MD; Carrie C. Zornosa, MSPH; Emily K. Bergsland, MD; Matthew H. Kulke, MD; Eric K. Nakakura, MD; Manisha H. Shah, MD pdf Download Poster (633 KB) C10 – Relationship Between Lanreotide Autogel, Chromogranin A and Progression- Free Survival in Patients with Gastroenteropancreatic Neuroendocrine Tumors Published in 2015 Listed under Clinical Download Bull-Bruna; Dehez; Mahon; Nguyen; Troconiz C10 – The Efficacy and Safety of Pasireotide (SOM230) in the Treatment of Patients with Metastatic Neuroendocrine Tumors (NET) Refractory or Resistant to Octreotide LAR Published in 2010 Listed under Clinical, Poster Download Larry Kvols, Bertram Wiedenmann, Kjell Öberg, Pharis Mohideen, Thomas M. O’Dorisio, Wouter W. de Herder, Gareth Hughes, Rudolf Arnold, Lowell Anthony pdf Download Poster (208 KB) C10 – The Efficacy and Safety of Sunitinib in Patients with Advanced Well-differentiated Pancreatic Neuroendocrine Tumors Published in 2016 Listed under Clinical Download Raymond C10 – Use of Molecular Profiling to Guide Treatment Decisions in Patients with Neuroendocrine Tumors Published in 2014 Listed under Clinical Download Cutler C10 – Neurokinin A Levels Predict Survival in Patients with Well Differentiated Small Bowel Neuroendocrine Tumors Published in 2011 Listed under Clinical, Poster Download Anne E. Diebold BS, J. Philip Boudreaux MD, Yi-Zarn Wang DDS, MD, Lowell B. Anthony MD, Ann Porter Uhlhorn RN, Pamela Ryan BSN, RN, Eugene A. Woltering MD pdf Download Poster (265 KB) C11 - Improvement of Carcinoid Syndrome (CS) Symptoms and Quality of Life (QoL) in CS Patients Treated with Somatostatin Analogs (SSAs) Published in 2018 Listed under Clinical, Poster Download Abstract ID: 26 Daniel M Halperin, Lynn Huynh, Jennifer L. Beaumont, Beilei Cai, Rachel Bhak, Sahil Narkhede, Mei S. Duh, Maureen P. Neary, David Cella pdf Download Poster (304 KB) C11 - Somatostatin Analog Use in Patients with Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Published in 2019 Listed under Clinical Download Taymeyah Al-Toubah; Mintallah Haider; Jonathan Strosberg Abstract ID: 126 C11 – A Prospective Trial on the Effect of Body Mass Index and Gender on Plasma Octreotide Levels in Patients Undergoing Long Term Therapy With Octreotide LAR Published in 2009 Listed under Clinical, Poster Download Saju Joseph, MD, Gang Li, PhD, Erika Lindholm, MD, Ying Zhou, MS, Vay Liang W. Go, MD, Aaron I. Vinik, MD, PhD, Thomas M. O’Dorisio, MD, Gregg Mamikunian, MS and Eugene A. Woltering, MD, FACS pdf Download Poster (120 KB) C11 – An Aggressive Multi-disciplinary Approach to Advanced Neuroendocrine Tumors Published in 2010 Listed under Clinical, Poster Download Shawn MacKenzie, Kambiz Kosari, Timothy Sielaff pdf Download Poster (12.75 MB) C11 – Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-free Survival and Overall Survival Published in 2015 Listed under Clinical, Poster Download Chen; Rose; White; El Haddad; Fidelman; Yarmohammadi; Sze; Salem; Metz; Soulen pdf Download Poster (3.88 MB) C11 – Integrated Safety Analysis of Telotristat Ethyl in Patients With Carcinoid Heart Disease Published in 2017 Listed under Clinical, Poster Download Lapuerta Abstract ID: 212 pdf Download Poster (263 KB) Select the number of documents per page 5 10 15 20 25 30 50 100 123…56»
